I drove its lattice-mcp tools by hand from a TypeScript client, checked every answer against grep, and hit five gotchas.

Un argumento polémico: Common Lisp como el mejor lenguaje de programación Common Lisp lleva más de tres décadas como ...

Two OpenAI Codex sandbox flaws, Overpatch and Heapjack, could let malicious repositories execute commands on developer systems.

Researchers escaped OpenAI's Codex sandbox two ways, one running commands on a developer's machine from its most locked-down mode. OpenAI has patched both.

langchain-quickjs 是 deepagents 生态中的一款中间件（middleware），它基于 quickjs-rs（通过 PyO3 + rquickjs 内嵌的 QuickJS 引擎）为 Agent 提供一个持久化、沙箱化的 JavaScript REPL 工具。本文围绕 README系统讲解 ...

Investors allege Replimune Group, Inc. built its RP1 regulatory strategy around single-arm trial designs the FDA had already questioned, including response criteria the agency said were not consistent ...

Like many great partnerships, it started with an argument. For months, Amjad Masad had been locked in a playful battle of wits with Haya Odeh, a young graphic designer at Boss Consulting SA, a web ...

A massive malvertising campaign is using fake Solana, Luno, and TradingView webpages with malicious JavaScript that instructs browsers to assemble malware directly in memory. The operation has been ...

Since the large language model (LLM) explosion started, companies have been trying to solve the problem of overflowing inboxes by using AI to categorize emails and draft replies that sound like you.

JavaScript Statistics: JavaScript is a type of scripting language for creating dynamic web page content. It designs elements to improve site visitors’ interlinkage with the web pages, such as animated ...

This project is a proof-of-concept that runs a JavaScript engine inside a web browser by compiling it to WebAssembly. The engine is Goja — a pure-Go implementation of ECMAScript 5.1 — and the ...

In July 2025, REPL announced it had received a CRL for its biologics license application (BLA) for RP1 (vusolimogene oderparepvec) plus nivolumab in advanced melanoma patients who were PD-1 ...